Sales revenue of 3,493 million euros, in constant currencies1 up 13.2 percent organically1 and up 15.1 percent including acquisitions (reported: up 21.0.
Sales revenue up 17.0 percent in constant currencies, underlying EBITDA margin at 35.0 percent Overall market situation characterized by innovations and strong.
/PRNewswire/ Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has agreed to acquire 100 percent of Albumedix Ltd..
AUBAGNE, France, July 21, 2022 Sales revenue up 22.1 percent in constant currencies, underlying EBITDA margin 35.2 percent 2022 outlook confirmed: Sales.